Europe Continuous Glucose Monitoring Market Size (2024 - 2029)

The market size for continuous glucose monitoring devices in Europe is experiencing significant growth, driven by an increasing diabetes population and the rising adoption of advanced monitoring technologies. This expansion is fueled by factors such as technological advancements that enhance the accuracy and user-friendliness of CGM devices, as well as heightened awareness among healthcare professionals and patients about the benefits of these devices. The European healthcare system, with its focus on universal coverage and access to innovative technologies, further supports the market's growth. As the demand for CGM devices continues to rise, it is expected to lead to further advancements in technology and improved diabetes care across the continent.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Monitoring Devices Research Europe Continuous Glucose Monitoring Market Market Size

Market Size of Europe Continuous Glucose Monitoring Industry

Europe Continuous Glucose Monitoring Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 2.04 Billion
Market Size (2029) USD 3.47 Billion
CAGR (2024 - 2029) 11.33 %

Major Players

Europe Continuous Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Europe Continuous Glucose Monitoring Market Analysis

The Europe Continuous Glucose Monitoring Market size is estimated at USD 2.04 billion in 2024, and is expected to reach USD 3.47 billion by 2029, growing at a CAGR of 11.33% during the forecast period (2024-2029).

In recent times, Europe has observed a significant rise in its diabetes population, a trend that mirrors global patterns. The prevalence of diabetes in Europe has been steadily increasing due to factors such as an aging population, changes in lifestyle habits, and genetic predispositions. This rise encompasses both type 1 and type 2 diabetes, leading to a greater demand for advanced technologies to effectively manage the condition.

A noteworthy development in diabetes management in Europe is the growing adoption of continuous glucose monitoring (CGM) devices. These devices offer a groundbreaking approach to monitoring blood glucose levels by providing real-time and continuous data. By eliminating the need for frequent fingerstick tests, CGM devices not only simplify the process but also provide individuals with valuable insights into their glucose patterns throughout the day and night.

The surge in CGM device usage across Europe can be attributed to various factors. Firstly, advancements in CGM technology have made these devices more accurate, reliable, and user-friendly, making them more appealing to individuals with diabetes. Additionally, increased awareness among healthcare professionals and patients about the benefits of CGM, such as improved glycemic control, reduced risk of hypoglycemia, and enhanced quality of life, has contributed to their widespread adoption.

Moreover, the European healthcare landscape, which emphasizes universal healthcare coverage and access to innovative medical technologies, has created a favorable environment for the expansion of the CGM market. Reimbursement policies in several European countries now include coverage for CGM devices for eligible patients, making them more accessible to a wider population.

In general, the rising number of diabetes cases in Europe, along with the increasing awareness of the advantages of continuous glucose monitoring, has led to a higher demand for CGM devices throughout the continent. This pattern is anticipated to persist in the future, stimulating more advancements in CGM technology and enhancing diabetes care results for people in Europe.

Europe Continuous Glucose Monitoring Industry Segmentation

Continuous glucose monitoring devices use glucose oxidase to measure blood sugar levels. In the sensor, platinum combines with glucose oxidase to produce hydrogen peroxidase, which then produces an electrical signal that is sent to the transmitter. Europe's continuous glucose monitoring market is segmented by components and geography. The report offers the value (in USD) and volume (in units) for the above segments. 

Continuous Glucose Monitoring
Sensors
Durables
Geography
France
Germany
Italy
Spain
Russia
United Kingdom
Rest of Europe
Need A Different Region Or Segment?
Customize Now

Europe Continuous Glucose Monitoring Market Size Summary

The European continuous glucose monitoring (CGM) market is experiencing significant growth, driven by the increasing prevalence of diabetes and the rising adoption of advanced monitoring technologies. The region has seen a notable rise in diabetes cases, attributed to factors such as an aging population, lifestyle changes, and genetic predispositions. This trend has led to a heightened demand for CGM devices, which offer real-time and continuous blood glucose monitoring, simplifying the management of diabetes and providing valuable insights into glucose patterns. The advancements in CGM technology have made these devices more accurate, reliable, and user-friendly, contributing to their widespread adoption across Europe. The emphasis on universal healthcare coverage and favorable reimbursement policies further supports the expansion of the CGM market, making these devices more accessible to a broader population.

The market is characterized by the presence of major players such as Dexcom, Abbott, and Medtronic, who hold significant market shares and are actively engaging in strategic mergers and acquisitions to expand their reach and enhance revenue streams. The introduction of innovative products, like Medtronic's Simplera and Ascensia's Eversense E3, highlights the ongoing advancements in CGM technology. These developments are expected to drive the market's growth, as they address the needs of both type 1 and type 2 diabetes patients, with a particular focus on improving glycemic control and reducing the risk of hypoglycemia. The increasing awareness of the benefits of CGM devices, coupled with the rising diabetes population, is anticipated to sustain the market's upward trajectory in the coming years.

Explore More

Europe Continuous Glucose Monitoring Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Continuous Glucose Monitoring

      1. 2.1.1 Sensors

      2. 2.1.2 Durables

    2. 2.2 Geography

      1. 2.2.1 France

      2. 2.2.2 Germany

      3. 2.2.3 Italy

      4. 2.2.4 Spain

      5. 2.2.5 Russia

      6. 2.2.6 United Kingdom

      7. 2.2.7 Rest of Europe

Europe Continuous Glucose Monitoring Market Size FAQs

The Europe Continuous Glucose Monitoring Market size is expected to reach USD 2.04 billion in 2024 and grow at a CAGR of 11.33% to reach USD 3.47 billion by 2029.

In 2024, the Europe Continuous Glucose Monitoring Market size is expected to reach USD 2.04 billion.

Europe Continuous Glucose Monitoring Market Report Snapshots

Continuous Glucose Monitor Market in Europe Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)